Cytek Biosciences

Public

Fremont, CaliforniaHealthcarehttps://www.cytekbio.com

Cytek Biosciences is now publicly traded

The data on this page reflects Cytek Biosciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jul 22, 2021

Last Round

Series D

Nov 5, 2020

Total Funding Raised

$332M

Company Overview

Cytek Biosciences operates in Healthcare and is based in Fremont, California. Its recorded funding history includes a Series D round in November 2020.

Cytek is a biotechnology company specializing in advanced cell analysis solutions that utilize innovative technologies to provide high-resolution and high-sensitivity flow cytometry.

Sector

Healthcare

AI Layer

Non-AI

Cytek Biosciences Comparables

Compare Cytek Biosciences with similar companies based on industry and business-model similarity.

Cytek Biosciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Beijing Challen Biotechnology Co., Ltd.	77%	Demo
Singleron Biotechnologies	67%	Demo
LumaCyte	66%	Demo

Book a demo to see all comparables

For institutional investors. Book with your work email.

Cytek Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO	Jul 22, 2021	Demo	Demo	Demo	Demo
Series D	Nov 5, 2020	Demo	Demo	Demo	Demo
Series C	Sep 25, 2018	Demo	Demo	Demo	Demo
Series B	Jan 25, 2017	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cytek Biosciences Investors

Notable investors and investment history

Cytek Biosciences investors
Investor	Rounds
RA Capital Management	Series D
Co-win Ventures	Series A, Series B
Hillhouse Investment	Series D
Bencao Capital	Series C
F-Prime Capital	Series B, Series A
Eight Roads Ventures	Series B, Series A
Northern Light Venture Capital	Series C